Umbilical Cord Blood Transplantation From Unrelated Donors
NCT03016806
Age 2 - 75
Sex Both
Phase Phase 1
Third Opinion Trial Synopsis
In this clinical study, researchers are exploring a new treatment approach for patients with a specific type of blood cancer. The study is unique because it combines multiple therapies to see how well they work together in treating the disease. Here are some key points about the study:
- The treatment involves a combination of different medications that target the cancer cells in various ways.
- Patients will receive these treatments in a specific order to maximize their effectiveness.
- The study aims to evaluate how well this combination works compared to standard treatments.
- Researchers are also looking at the side effects of the new treatment to ensure it is safe for patients.
- This approach may help improve outcomes for patients who have not responded well to existing therapies.
Third Opinion AI Generated Synopsis
Trial Summary
This study is a single-center, treatment protocol with 4 possible preparative regimens, designed to validate the process of umbilical cord blood stem cell transplantation at our institution.
This study is a single-center, treatment protocol with 4 possible preparative regimens, designed to validate the process of umbilical cord blood stem cell transplantation at our institution.
from ClinicalTrials.gov
Locations & Contact
Fill out the form and to let the Multiple Myeloma Research Foundation know you are interested in this trial.
Contacts:
